115 related articles for article (PubMed ID: 9704618)
1. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.
Mangano WE; Cagle PT; Churg A; Vollmer RT; Roggli VL
Am J Clin Pathol; 1998 Aug; 110(2):191-9. PubMed ID: 9704618
[TBL] [Abstract][Full Text] [Related]
2. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.
Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Sato A; Tsujimura T; Ueda H; Makihata S; Kato F; Iwasaki A; Nabeshima K
Lung Cancer; 2018 Nov; 125():198-204. PubMed ID: 30429020
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis of desmoplastic malignant mesothelioma.
Colby TV
Am J Clin Pathol; 1998 Aug; 110(2):135-6. PubMed ID: 9704609
[No Abstract] [Full Text] [Related]
4. Desmoplastic malignant mesothelioma: two cases and a literature review.
Hirano H; Maeda H; Sawabata N; Okumura Y; Takeda S; Maekura R; Ito M; Maeda T; Nakane S; Uematsu K
Med Electron Microsc; 2003 Sep; 36(3):173-8. PubMed ID: 14505061
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of cytokeratins 7, 8, 17, 18, and 19, and GLUT-1 aids differentiation of desmoplastic malignant mesothelioma from fibrous pleuritis.
Horiuchi T; Ogata S; Tominaga S; Hiroi S; Kawahara K; Hebisawa A; Irei I; Ito I; Kameya T; Tsujimura T; Nakano T; Nakanishi K; Kawai T
Histol Histopathol; 2013 May; 28(5):663-70. PubMed ID: 23224745
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
Wu D; Hiroshima K; Matsumoto S; Nabeshima K; Yusa T; Ozaki D; Fujino M; Yamakawa H; Nakatani Y; Tada Y; Shimada H; Tagawa M
Am J Clin Pathol; 2013 Jan; 139(1):39-46. PubMed ID: 23270897
[TBL] [Abstract][Full Text] [Related]
7. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
8. Pathohistological diagnosis and differential diagnosis.
Tischoff I; Neid M; Neumann V; Tannapfel A
Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
[TBL] [Abstract][Full Text] [Related]
9. Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review.
Hashimoto K; Okuma Y; Hosomi Y; Hishima T
BMC Cancer; 2016 Sep; 16(1):718. PubMed ID: 27599565
[TBL] [Abstract][Full Text] [Related]
10. [Autopsy case of sarcomatoid malignant pleural mesothelioma].
Ogura H; Naoki K; Togashi I; Kunikane H; Okamoto H; Hida N; Narita Y; Kase M; Oosawa H; Oomori T; Watanabe K
Nihon Kokyuki Gakkai Zasshi; 2006 Oct; 44(10):689-94. PubMed ID: 17087333
[TBL] [Abstract][Full Text] [Related]
11. Spindle cell tumors of the pleura: differential diagnosis.
Rdzanek M; Fresco R; Pass HI; Carbone M
Semin Diagn Pathol; 2006 Feb; 23(1):44-55. PubMed ID: 17044195
[TBL] [Abstract][Full Text] [Related]
12. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.
Kwee WS; Veldhuizen RW; Golding RP; Mullink H; Stam J; Donner R; Boon ME
Virchows Arch A Pathol Anat Histol; 1982; 397(3):287-99. PubMed ID: 6186071
[TBL] [Abstract][Full Text] [Related]
13. The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas.
Churg A; Cagle P; Colby TV; Corson JM; Gibbs AR; Hammar S; Ordonez N; Roggli VL; Tazelaar HD; Travis WD; Wick M;
Am J Surg Pathol; 2011 Dec; 35(12):1823-9. PubMed ID: 21959310
[TBL] [Abstract][Full Text] [Related]
14. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma.
Epstein JI; Budin RE
Hum Pathol; 1986 May; 17(5):514-9. PubMed ID: 2422109
[TBL] [Abstract][Full Text] [Related]
15. Unusual presentations of thoracic tumors: Case 2. Malignant mesothelioma mimicking rheumatoid pleurisy.
Nanke Y; Akama H; Hebisawa A; Suzuki M; Akagawa S; Tateishi M; Yamagata H; Kawai T; Kamatani N
J Clin Oncol; 2001 Sep; 19(17):3782-4. PubMed ID: 11533103
[No Abstract] [Full Text] [Related]
16. Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases.
Adams VI; Unni KK; Muhm JR; Jett JR; Ilstrup DM; Bernatz PE
Cancer; 1986 Oct; 58(7):1540-51. PubMed ID: 3742473
[TBL] [Abstract][Full Text] [Related]
17. How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study.
Husain AN; Mirza MK; Gibbs A; Hiroshima K; Chi Y; Boumendjel R; Stang N; Krausz T; Galateau-Salle F
Lung Cancer; 2014 Mar; 83(3):324-8. PubMed ID: 24440278
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma.
Kato Y; Tsuta K; Seki K; Maeshima AM; Watanabe S; Suzuki K; Asamura H; Tsuchiya R; Matsuno Y
Mod Pathol; 2007 Feb; 20(2):215-20. PubMed ID: 17192790
[TBL] [Abstract][Full Text] [Related]
19. Use of Programmed Death Ligand-1 (PD-L1) Staining to Separate Sarcomatoid Malignant Mesotheliomas From Benign Mesothelial Reactions.
Derakhshan F; Ionescu D; Cheung S; Churg A
Arch Pathol Lab Med; 2020 Feb; 144(2):185-188. PubMed ID: 31484000
[TBL] [Abstract][Full Text] [Related]
20. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.
Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
J Clin Pathol; 2013 Oct; 66(10):854-61. PubMed ID: 23833051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
